Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

417 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial.
Mpofu R, Otwombe K, Mlisana K, Nchabeleng M, Allen M, Kublin J, McElrath MJ, Bekker LG, Churchyard G, Gray G, Laher F. Mpofu R, et al. Among authors: mcelrath mj. PLoS One. 2021 Jan 22;16(1):e0241708. doi: 10.1371/journal.pone.0241708. eCollection 2021. PLoS One. 2021. PMID: 33481787 Free PMC article. Clinical Trial.
Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial.
Spearman P, Kalams S, Elizaga M, Metch B, Chiu YL, Allen M, Weinhold KJ, Ferrari G, Parker SD, McElrath MJ, Frey SE, Fuchs JD, Keefer MC, Lubeck MD, Egan M, Braun R, Eldridge JH, Haynes BF, Corey L; NIAID HIV Vaccine Trials Network. Spearman P, et al. Among authors: mcelrath mj. Vaccine. 2009 Jan 7;27(2):243-9. doi: 10.1016/j.vaccine.2008.10.051. Epub 2008 Nov 7. Vaccine. 2009. PMID: 18996425 Free PMC article. Clinical Trial.
Post-step modifications for research on HIV vaccines.
Corey L, McElrath MJ, Kublin JG. Corey L, et al. Among authors: mcelrath mj. AIDS. 2009 Jan 2;23(1):3-8. doi: 10.1097/QAD.0b013e32830e6d6d. AIDS. 2009. PMID: 19050380 Free PMC article. Review. No abstract available.
Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk.
Lingappa JR, Hughes JP, Wang RS, Baeten JM, Celum C, Gray GE, Stevens WS, Donnell D, Campbell MS, Farquhar C, Essex M, Mullins JI, Coombs RW, Rees H, Corey L, Wald A; Partners in Prevention HSV/HIV Transmission Study Team. Lingappa JR, et al. PLoS One. 2010 Sep 13;5(9):e12598. doi: 10.1371/journal.pone.0012598. PLoS One. 2010. PMID: 20856886 Free PMC article. Clinical Trial.
Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054).
Peiperl L, Morgan C, Moodie Z, Li H, Russell N, Graham BS, Tomaras GD, De Rosa SC, McElrath MJ; NIAID HIV Vaccine Trials Network. Peiperl L, et al. Among authors: mcelrath mj. PLoS One. 2010 Oct 27;5(10):e13579. doi: 10.1371/journal.pone.0013579. PLoS One. 2010. PMID: 21048953 Free PMC article. Clinical Trial.
Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial.
Campbell MS, Mullins JI, Hughes JP, Celum C, Wong KG, Raugi DN, Sorensen S, Stoddard JN, Zhao H, Deng W, Kahle E, Panteleeff D, Baeten JM, McCutchan FE, Albert J, Leitner T, Wald A, Corey L, Lingappa JR; Partners in Prevention HSV/HIV Transmission Study Team. Campbell MS, et al. PLoS One. 2011 Mar 2;6(3):e16986. doi: 10.1371/journal.pone.0016986. PLoS One. 2011. PMID: 21399681 Free PMC article. Clinical Trial.
417 results